Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01291
http://purl.obolibrary.org/obo/dinto_DB01291
|
|---|---|
| Preferred Name | pirbuterol |
| Synonyms |
6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
C12H20N2O3
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | pirbuterol
|
|---|---|
| label | pirbuterol
|
| DBSynonym |
pirbuterol hydrochloride
pirbuterolum [inn-latin]
|
| ATCCode |
R03AC08
R03CC07
|
| Definition | Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.
The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3? ,5?-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| activates | |
| type | |
| InChIKey | InChIKey=VQDBNKDJNJQRDG-UHFFFAOYSA-N
|
| Synonym |
6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
C12H20N2O3
|
| xref |
PubChem Compound:4845
National Drug Code Directory:0089-0815-21
Drugs.com:http://www.drugs.com/cdi/pirbuterol.html
ChemSpider:4679
RxList:http://www.rxlist.com/cgi/generic/pirbu.htm
PubChem Substance:46506379
PharmGKB:PA450983
See more
See less
|
| CASRN | 38677-81-5
|
| prefixIRI | obo2:dinto_DB01291
|
| SMILES | CC(C)(C)NCC(O)C1=NC(CO)=C(O)C=C1
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C12H20N2O3/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8/h4-5,11,13,15-17H,6-7H2,1-3H3
|
| DBBrand | maxair
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |